Focused Alpha’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Focused Alpha's ABBV Position: Q3 2026 in Review
Focused Alpha increased its AbbVie (ABBV) stake by 109% in Q3 2026, buying an estimated $623K and bringing the position to 4,657 shares worth $1.22M. The position accounts for 0.3% of the portfolio, ranked #56.
Focused Alpha first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Focused Alpha held 4,657 shares of AbbVie worth $1.22M as of Q3 2026.
- Focused Alpha bought 2,429 AbbVie shares in Q3 2026, an estimated $623K.
- AbbVie made up 0.3% of Focused Alpha's portfolio in Q3 2026, its #56 holding.
- Focused Alpha first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
- 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.